Caffeine for preterm infants: current indications and uncertainties

Caffeine for preterm infants: current indications and uncertainties

Authors

  • S. Nobile Neonatology Unit, Salesi Children’s Hospital, Ancona (Italy)
  • V. P. Carnielli Neonatology Unit, Salesi Children’s Hospital, Ancona (Italy)

Keywords:

caffeine, preterm infant, apnea, bronchopulmonary dysplasia

Abstract

Caffeine is one of the most commonly used therapies in Neonatology, with different indications such as the treatment of apnea and the prevention of extubation failure and bronchopulmonary dysplasia. However, there are still uncertainties regarding effects on central nervous system development, time of discontinuation and dosing of the drug.

Downloads

Published

29-06-2015

How to Cite

1.
Caffeine for preterm infants: current indications and uncertainties. Acta Biomed [Internet]. 2015 Jun. 29 [cited 2024 Jun. 16];86(1S):32-5. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/4542